HPV Summit: Global Progress Towards Primary HPV Screening and its Impact on US Cervical Cancer Screening Policy

HPV Summit: Global Progress Towards Primary HPV Screening and its Impact on US Cervical Cancer Screening Policy

Join Dr. Wright, Dr. Huh, and Prof. Garland as they discuss HPV Primary Screening, vaccination, and global impact of future screening efforts.

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Dr. Thomas Wright, Dr. Warner Huh, and Professor Suzanne Garland will have a wide-ranging discussion about HPV primary screening, both in the United States, as well as globally.  They will also discuss HPV vaccination and how vaccination is going to impact future screening efforts, both in the United States and in Australia.  

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host: 

    Thomas C. Wright, Jr., MD
    Professor Emeritus of Pathology and Cell Biology
    Columbia University
    New York, NY

    Financial Disclosure:
    Consulting Fees: Abbott, BD, Roche
    Contracted Research: BD, Inovio, Roche

    Faculty:

    Professor Suzanne Garland, MBBS, MD, FRCPA ,FRANZCOG Ad Eundem, FAChSHM
    Director of Microbiology and Infectious Diseases
    Head of Clinical Microbiology and Infectious Diseases
    Royal Women's Hospital
    Senior Consultant Microbiology
    Royal Children's Hospital
    Honorary Research Fellow
    Murdoch Children’s Research Institute
    Victoria, Australia

    Financial Disclosure:
    Consulting Fees: Merck 
    Speakers Bureau: MSD, SPMSD
    Contracted Research: Commonwealth Dept. of Health, CSL, GSK, Merck

    Warner K. Huh, MD
    Division Director and Professor, Division of Gynecologic Oncology
    Margaret Cameron Spain Endowed Chair in Obstetrics/Gynecology
    University of Alabama at Birmingham
    Birmingham, AL

    Financial Disclosure:
    Consulting Fees: Incell Dx, TheVax

    Reviewers/Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Kenneth Brown has nothing to disclose.
    • Carole Drexel, PhD has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Kia K. Gray, MPH has nothing to disclose.
  • Learning Objectives

    Upon completion of this CME activity, participants who manage patients at risk for cervical cancer should be better able to:

    • Recognize the scientific and clinical foundation supporting primary HPV screening when assessing a woman’s risk for developing cervical cancer.
    • Evaluate and adopt into their clinical practice emergent USPSTF draft recommendations that help to simplify and harmonize cervical cancer screening in the US and abroad.
    • Appreciate the value primary HPV testing brings to improving patient outcomes, along with recognition that US cervical cancer screening policy will likely need to be reviewed over time as HPV vaccination takes a stronger hold in the US.
  • Target Audience

    This activity is designed to meet the educational needs of the obstetrician and gynecologist, family physician, internal medicine physician, physician assistant, nurse practitioner, and certified nurse midwife.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

  • Commercial Support

    This activity is supported by an independent educational grant from Roche Diagnostics.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Sign-up for the Global Women's Health Academy newsletters.
Comprehensive Women's Health Education.

Better education for a better you.

* Required
Optional